The pharmacologic closure of the patent ductus arteriosus
- 15 December 2004
- journal article
- review article
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 10 (2), 177-184
- https://doi.org/10.1016/j.siny.2004.10.003
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Prostaglandin E 2 —Mediated Relaxation of the Ductus ArteriosusCirculation, 2004
- Mechanics of Breathing after Surgical Ligation of Patent Ductus arteriosus in Newborns with Respiratory Distress SyndromeNeonatology, 2004
- Effect of ibuprofen on bilirubin-albumin bindingThe Journal of Pediatrics, 2004
- Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infantsPublished by Wiley ,2003
- Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infantsPublished by Wiley ,2003
- Two Types of Microsomal Prostaglandin E Synthase: Glutathione-Dependent and -Independent Prostaglandin E SynthasesBiochemical and Biophysical Research Communications, 1997
- Recommendations for the postnatal use of indomethacin: An analysis of four separate treatment strategiesThe Journal of Pediatrics, 1996
- Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase IINature, 1995
- Persistent responsiveness of the neonatal ductus arteriosus in immature lambs: a possible cause for reopening of patent ductus arteriosus after indomethacin-induced closure.Circulation, 1985
- Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative studyThe Journal of Pediatrics, 1983